Our systems undervalue prevention – FASD is a case in point

May 2022
Australia spends less than 2% per annum of its health budget on prevention. With a particular focus on Fetal Alcohol Spectrum Disorder (FASD), this Opinion Piece outlines the significant potential return of greater investment.
Read more
February 2022

Supporting peer workers and beyond: priorities for AOD workforce development

November 2021

No time to waste: Ageing, alcohol and pharmaceuticals

Co-authors: Ya Ping Lee, Fran Ackermann and Jun Chih, Curtin University, and Christopher Etherton-Beer, University of Western Australia
July 2021

Challenges and risks associated with the use of linked data and machine learning to address the opioid crisis

Co-authors: Professor Matthew Hickman, Dr Sebastiano Barbieri, and Professor Louisa Degenhardt
May 2021

Behind the curtain: Aboriginal girls and young women ‘voice’ their solutions for a stronger future

March 2021

Evaluation of the Assertive Outreach Services Program Pilot

October 2020

The NSW Drug Court and Evidence-Based Policy

August 2020

Implementing take-home naloxone in Australia: We’ve come a long way but there’s still a long way to go

May 2020

Managing AOD use in times of crisis – what the sector can do to support our workforce

In this edition of Drug and Alcohol Research Connections, NCETA, NDARC and NDRI have endeavoured to provide people working in the AOD sector with info
February 2020

New Extended Release Buprenorphine (XR-BPN) research and where to next

December 2019

Up in smoke: The extraordinary cost of smoking to Australia

Tobacco is responsible for the preventable deaths of 20,000 Australians each year, and the cost to them and to the wider community is high.

Pages